Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term

Cited by (214)

Items 101–200 of 214

1. Intranasal Rotenone Induces Alpha-Synuclein Accumulation, Neuroinflammation and Dopaminergic Neurodegeneration in Middle-Aged Mice
   Monika Sharma, Nishant Sharma, Amit Khairnar · 2022 · Neurochemical Research
2. ⍺-Synuclein Structural Diversity and the Cellular Environment in ⍺-Synuclein Transmission Models and Humans
   Wouter Peelaerts, Veerle Baekelandt · 2023 · Neurotherapeutics
3. Brain olfactory‐related atrophy in isolated rapid eye movement sleep behavior disorder
   Kyung Ah Woo, Heejung Kim, Eun Jin Yoon, Jung Hwan Shin, Hyunwoo Nam, Beomseok Jeon, Yu Kyeong Kim, Jee‐Young Lee · 2023 · Annals of Clinical and Translational Neurology
4. α-Synuclein–induced Kv4 channelopathy in mouse vagal motoneurons drives nonmotor parkinsonian symptoms
   Wei‐Hua Chiu, Lora Kovacheva, Ruth E. Musgrove, Hadar Arien‐Zakay, James B. Koprich, Jonathan M. Brotchie, Rami Yaka, Danny Ben‐Zvi, Menachem Hanani, Jochen Roeper et al. · 2021 · Science Advances
5. Evaluation of the Neuroanatomical Basis of Olfactory Dysfunction in the General Population
   Ran Lu, N. Ahmad Aziz, Martin Reuter, Tony Stöcker, Monique M.B. Breteler · 2021 · JAMA Otolaryngology–Head & Neck Surgery
6. Is Multiple System Atrophy a Prion-like Disorder?
   K. A. Jellinger, Gregor Karl Wenning, Nadia Stefanova · 2021 · International Journal of Molecular Sciences
7. Specific immune modulation of experimental colitis drives enteric alpha-synuclein accumulation and triggers age-related Parkinson-like brain pathology
   Grathwohl, Stefan, Quansah, Emmanuel, Maroof, Nazia, Steiner, Jennifer A, Spycher, Liz, Benmansour, Fethallah, Duran-Pacheco, Gonzalo, Siebourg-Polster, Juliane, Oroszlan-Szovik, Krisztina, Remy, Helga et al. · 2020
8. A human striatal–midbrain assembloid model of alpha-synuclein propagation
   Hoang‐Dai Tran, Min‐Kyoung Shin, Xin Yi Yeo, Sangyong Jung, Muhammad Junaid, Su Bin Lim, Jungmo Kim, Hyun Goo Woo, Charlotte R. Denman, Run-Run Han et al. · 2025 · Brain
9. α-Synuclein in Parkinson’s Disease: Does a Prion-Like Mechanism of Propagation from Periphery to the Brain Play a Role?
   Huimin Zheng, Changhe Shi, Haiyang Luo, Liyuan Fan, Zhihua Yang, Xinchao Hu, Zhongxian Zhang, Shuo Zhang, Zhengwei Hu, Yu Fan et al. · 2020 · The Neuroscientist
10. Loss of One Engrailed1 Allele Enhances Induced α-Synucleinopathy
    Diptaman Chatterjee, Daniel Saiz‐Sánchez, Emmanuel Quansah, Nolwen L. Rey, Sonia George, Katelyn Becker, Zachary Madaj, Jennifer A. Steiner, Jiyan Ma, Martha L. Escobar Galvis et al. · 2019 · Journal of Parkinson s Disease
11. Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain
    Shuyu Zhang, Karina Joppe, Timo Strohäker, Lars Tatenhorst, Lucas Caldi Gomes, Simon Mayer, Byung Chul Jung, Woojin Scott Kim, Seung‐Jae Lee, Stefan Becker et al. · 2023 · Brain Pathology
12. Perturbation of in vivo Neural Activity Following α-Synuclein Seeding in the Olfactory Bulb
    Aishwarya S. Kulkarni, María del Mar Cortijo, Elizabeth R. Roberts, Tamara L. Suggs, Heather B. Stover, Jose Ignacio Pena-Bravo, Jennifer A. Steiner, Kelvin C. Luk, Patrik Brundin, Daniel W. Wesson · 2020 · Journal of Parkinson s Disease
13. α-synucleinopathy exerts sex-dimorphic effects on the multipurpose DNA repair/redox protein APE1 in mice and humans
    Kristin M. Miner, Anuj S. Jamenis, Tarun N. Bhatia, Rachel N. Clark, Dhivyaa Rajasundaram, Sylvie Sauvaigo, Daniel M. Mason, Jessica M. Posimo, Nevil Abraham, Brett A. DeMarco et al. · 2022 · Progress in Neurobiology
14. Neurodegeneration and contralateral α-synuclein induction after intracerebral α-synuclein injections in the anterior olfactory nucleus of a Parkinson’s disease A53T mouse model
    Alicia Flores‐Cuadrado, Daniel Saiz‐Sánchez, Alicia Mohedano‐Moriano, Alino Martı́nez-Marcos, Isabel Úbeda‐Bañón · 2019 · Acta Neuropathologica Communications
15. Infections in the Etiology of Parkinson’s Disease and Synucleinopathies: A Renewed Perspective, Mechanistic Insights, and Therapeutic Implications
    Gabriela Mercado, Christopher Käufer, Franziska Richter, Wouter Peelaerts · 2024 · Journal of Parkinson s Disease
16. Conditioning Against the Pathology of Parkinson's disease.
    Rehana K. Leak · 2018 · PubMed
17. An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of α-synuclein
    Eleanna Kara, Alessandro Crimi, Anne E. Wiedmer, Marc Emmenegger, Claudia Manzoni, Sara Bandrés‐Ciga, Karishma D’Sa, Regina Hertfelder Reynolds, Juan Antonio Botía, Marco Losa et al. · 2021 · Cell Reports
18. Behavioral and neurochemical impairments after intranasal administration of chlorpyrifos formulation in mice
    Cristina Eugenia Gallegos, Mariana Bartos, Fernanda Gumilar, Alejandra Minetti, Carlos Javier Baier · 2022 · Pesticide Biochemistry and Physiology
19. α-Synuclein in Parkinson's Disease: 12 Years Later
    Kostas Vekrellis, Evangelia Emmanouilidou, Maria Xilouri, Leonidas Stefanis · 2024 · Cold Spring Harbor Perspectives in Medicine
20. Lewy body diseases and the gut
    Timothy Robert Sampson, Malú G. Tansey, Andrew B. West, Rodger A. Liddle · 2025 · Molecular Neurodegeneration
21. Experimental colitis drives enteric alpha-synuclein accumulation and Parkinson-like brain pathology
    Stefan A. Grathwohl, Emmanuel Quansah, Nazia Maroof, Jennifer A. Steiner, Liz Spycher, Fethallah Benmansour, Gonzalo Durán-Pacheco, Juliane Siebourg‐Polster, Krisztina Oroszlan‐Szovik, Helga Remy et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
22. A 14-day pulse of PLX5622 modifies α-synucleinopathy in preformed fibril-infused aged mice of both sexes
    Tarun N. Bhatia, Anuj S. Jamenis, Muslim Abbas, Rachel N. Clark, Kristin M. Miner, Manisha N. Chandwani, Roxanne E. Kim, William C. Hilinski, Lauren A. O’Donnell, Kelvin C. Luk et al. · 2023 · Neurobiology of Disease
23. Parkinson's disease pathology is directly correlated to SIRT3 in human subjects and animal models: Implications for AAV.SIRT3-myc as a disease-modifying therapy
    Dennison Trinh, Ahmad R. Israwi, Harsimar Brar, Jose E.A. Villafuerte, Ruella Laylo, Humaiyra Patel, Sabika Jafri, Lina Al Halabi, Shaumia Sinnathurai, Kiran Reehal et al. · 2023 · Neurobiology of Disease
24. Are Preformed Fibrils a Model of Parkinson’s Disease?
    Amanda L. Woerman, Kelvin C. Luk · 2024 · Journal of Parkinson s Disease
25. Impact of the COVID-19 Pandemic on Chronic Neurological Disorders: Focus on Patients with Dementia
    Natasha Irrera, María Antonietta Barbieri, Gianluca Bagnato, Carmelo Ioppolo, Antonio Giovanni Versace · 2022 · CNS & Neurological Disorders - Drug Targets
26. Air pollution nanoparticle and alpha-synuclein fibrils synergistically decrease glutamate receptor A1, depending upon nPM batch activity
    Hongqiao Zhang, Carla D’Agostino, Christopher T. Tulisiak, Max Andrew Thorwald, Liza Bergkvist, Allison Lindquist, Lindsay K. Meyerdirk, Emily Schulz, Katelyn Becker, Jennifer A. Steiner et al. · 2023 · Heliyon
27. The role of L-DOPA in neurological and neurodegenerative complications: a review
    Sudheendra Rao Kulkarni, Bothe Thokchom, Megha B. Abbigeri, Santosh Mallikarjun Bhavi, Sapam Riches Singh, Nitish Metri, Ramesh Babu Yarajarla · 2025 · Molecular and Cellular Biochemistry
28. Age-dependent progression from clearance to vulnerability in the early response of periventricular microglia to α-synuclein toxic species
    Ma Salomé Sirerol-Piquer, Ana Pérez‐Villalba, Pere Duart-Abadía, Germán Belenguer, Ulises Gómez‐Pinedo, Laura Blasco-Chamarro, Pau Carrillo-Barberà, Azucena Pérez‐Cañamás, Victoria Navarro, Benjamin Dehay et al. · 2025 · Molecular Neurodegeneration
29. Heat Shock Protein 70 as a Sex-Skewed Regulator of α-Synucleinopathy
    Tarun N. Bhatia, Rachel N. Clark, Patrick G. Needham, Kristin M. Miner, Anuj S. Jamenis, Elizabeth A. Eckhoff, Nevil Abraham, Xiaoming Hu, Peter Wipf, Kelvin C. Luk et al. · 2021 · Neurotherapeutics
30. Single-dose intranasal administration of α-syn PFFs induce lewy neurite-like pathology in olfactory bulbs
    Masanori Sawamura, Junichiro Ohira, Rie Hikawa, Tomoyuki Ishimoto, Etsuro Nakanishi, Hodaka Yamakado, Ryōsuke Takahashi · 2023 · Parkinsonism & Related Disorders
31. Aging, Parkinson’s Disease, and Models: What Are the Challenges?
    Ilaria Bellantuono, Heather Mortiboys, Emily M. Rocha, Manish Chamoli, Shankar J. Chinta, Julie Kay Andersen, Ruby Wallis, Erwan Bézard, Matt Goldberg, Tim Greenamyre et al. · 2023
32. Effect of host and strain factors on α-synuclein prion pathogenesis
    Amanda L. Woerman, Jason C. Bartz · 2024 · Trends in Neurosciences
33. Alpha-synuclein pathology and Parkinson’s disease-related olfactory dysfunctions: an update on preclinical models and therapeutic approaches
    Jancy Nixon Abraham, Devesh Rawat, Priyadharshini Srikanth, Lisni P. Sunny, Nixon M. Abraham · 2025 · Mammalian Genome
34. Synapses do not facilitate prion-like transfer of alpha-synuclein: a quantitative study in reconstructed unidirectional neural networks
    Josquin Courte, Ngoc Anh Le, Teng Pan, Luc Bousset, Ronald Melki, Catherine Villard, Jean‐Michel Peyrin · 2023 · Cellular and Molecular Life Sciences
35. In vivo modeling of prodromal stage of Parkinson’s disease
    Silvia Cerri, Fabio Blandini · 2020 · Journal of Neuroscience Methods
36. Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases
    Shun Yoshida, Takafumi Hasegawa · 2022 · Neurochemistry International
37. Pathological α-synuclein perturbs nuclear integrity
    Michael Millett, Allison Comite, Elisabeth Martin Castosa, Anika J. Heuberger, Preston Wagner, Ignacio Gallardo, Jessica Reinhardt, Nicole Chambers, Dominic Hall, Evan Miller et al. · 2025 · Neurobiology of Disease
38. α‐Synuclein decoy peptide protects mice against α‐synuclein‐induced memory loss
    Qingyun Guo, K. Kawahata, Wenbin Jia, Haoyang Wang, An Cheng, Yasushi Yabuki, Norifumi Shioda, Kohji Fukunaga · 2023 · CNS Neuroscience & Therapeutics
39. Prodromal Parkinson's disease and the catecholaldehyde hypothesis: Insight from olfactory bulb organotypic cultures
    Enrico Bagnoli, Alexandre Trotier, Jill M. McMahon, Leo R. Quinlan, Manus Jonathan Paul Biggs, Abhay S. Pandit, Una FitzGerald · 2023 · The FASEB Journal
40. FRET-Based Screening Identifies p38 MAPK and PKC Inhibition as Targets for Prevention of Seeded α-Synuclein Aggregation
    Alexander Svanbergsson, Fredrik Ek, Isak Martinsson, Jordi Rodo, Di Liu, Edoardo Brandi, Caroline Haikal, Laura Torres-Garcia, Wen Li, Gunnar K. Gouras et al. · 2021 · Neurotherapeutics
41. Infections and Changes in Commensal Bacteria and the Pathogenesis of Parkinson’s Disease
    Kathleen M. Shannon · 2022 · Journal of Parkinson s Disease
42. Mitral cells and the glucagon‐like peptide 1 receptor: The sweet smell of success?
    Enrico Bagnoli, Una FitzGerald · 2018 · European Journal of Neuroscience
43. Olfactory Dysfunction: An early indicator of parkinson's disease
    Durlav Chowdhury, Ashmita Das, Mrityunjay Mishra, Jayashree, Arijit Das, Surendra Haribhau Bodakhe · 2025 · Brain Disorders
44. REM sleep behavior and olfactory dysfunction: Enhancing the utility and translation of animal models in the search for precision medicines for Parkinson's disease
    Abdallah Ahnaou, Wilhelmus H. I. M. Drinkenburg · 2022 · Neuroscience & Biobehavioral Reviews
45. Failure of Diphtheria Toxin Model to Induce Parkinson-Like Behavior in Mice
    Lucie Valek, Irmgard Tegeder · 2021 · International Journal of Molecular Sciences
46. Structural Variations of Prions and Prion-like Proteins Associated with Neurodegeneration
    Carter Sky Christensen, Sean Wang, Wenshu Li, Danyang Yu, Henry James Li · 2024 · Current Issues in Molecular Biology
47. Altered ATP13A2/PARK9 Levels Influence α-Synuclein Accumulation in Neurons via Phagocytosis and Secretion in Glial Cells
    Taiji Tsunemi, Yuta Ishiguro, Asako Yoroisaka, Dou Feng, Nobutaka Hattori · 2025 · Cells
48. Key Connectomes and Synaptic‐Compartment‐Specific Risk Genes Drive Pathological α‐Synuclein Spreading
    Yuanxi Li, Justin Torok, Shujing Zhang, Jessica L. Ding, Ning Wang, Courtney Lau, Shruti Kulkarni, Chaitali Anand, Julie Tran, Michael Cheng et al. · 2025 · Advanced Science
49. Drug discovery and development for Parkinson’s disease: are preclinical models good enough?
    Alejandro Reinares-Sebastián, Noelia Esteban-García, Masahiko Takada, Inés Trigo‐Damas · 2025 · Frontiers in Aging Neuroscience
50. Immunotherapeutic interventions in Parkinson's disease: Focus on α-Synuclein
    Upasana Ganguly, Sukhpal Singh, Sasanka Chakrabarti, Adesh Kumar Saini, Reena Vohra Saini · 2022 · Advances in protein chemistry and structural biology
51. Investigating key factors underlying neurodegeneration linked to alpha‐synuclein spread
    Cindy Chi-Ching Pang, Maja Højvang Sørensen, Krit Lee, Kelvin C. Luk, John Q. Trojanowski, Virginia M.‐Y. Lee, Wendy J. Noble, Raymond Chuen‐Chung Chang · 2022 · Neuropathology and Applied Neurobiology
52. Molecular analysis of network vulnerability to α-synuclein pathology reveals PAKs as therapeutic targets for Parkinson’s disease
    Naman Vatsa, Julia K. Brynildsen, Thomas M. Goralski, Kevin Kurgat, Lindsay K. Meyerdirk, Elizabeth Breton, Daniella DeWeerd, Laura Brasseur, Lisa Turner, Katelyn Becker et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
53. Selective neurodegeneration generated by intravenous α‐synuclein pre‐formed fibril administration is not associated with endogenous α‐synuclein levels in the rat brain
    Wei‐Li Kuan, Maha Alfaidi, Catherine B. Horne, Benjamin Vallin, Sarah Emma Fox, Shaline V. Fazal, Caroline H. Williams‐Gray, Roger A. Barker · 2022 · Brain Pathology
54. Ion channel dysregulation and cellular adaptations to alpha-synuclein in stressful pacemakers of the parkinsonian brainstem
    Wei‐Hua Chiu, Nadine Wattad, Joshua A. Goldberg · 2024 · Pharmacology & Therapeutics
55. Low-density lipoprotein receptor–related protein 1 mediates α-synuclein transmission from the striatum to the substantia nigra in animal models of Parkinson’s disease
    Hanjiang Luo, Caixia Peng, C.-S.C. Wu, Chengwei Liu, Qinghua Li, Shun Yu, Jia Liu, Min Chen · 2024 · Neural Regeneration Research
56. Editorial: Pathogenic templating proteins in Neurodegenerative Disease
    Laura A. Volpicelli‐Daley, Patrik Brundin · 2017 · Neurobiology of Disease
57. Lysosomal Exocytosis Releases Pathogenic α-Synuclein Species from Neurons
    Ying Xue Xie, Nima N. Naseri, Jasmine A. Fels, Parinati Kharel, Yoonmi Na, Jacqueline Burré, Manu Sharma · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
58. Untangling the heart–brain connection in Parkinson’s disease: emerging mechanisms and models
    Alessandra Martello, Vincenzo Lionetti · 2025 · Canadian Journal of Physiology and Pharmacology
59. Lack of Parkinsonian Pathology and Neurodegeneration in Mice After Long-Term Injections of a Proteasome Inhibitor in Olfactory Bulb and Amygdala
    Natalia López‐González del Rey, Tiziano Balzano, Lucia Martin-Rodriguez, Constanza Salinas-Rebolledo, Inés Trigo‐Damas, Alejandro Rojas‐Fernández, Lydia Alvarez‐Erviti, Javier Blesa · 2021 · Frontiers in Aging Neuroscience
60. Modeling synucleinopathies in rodents
    Anna Barber Janer, Eline Vonck, Veerle Baekelandt · 2021 · International review of movement disorders
61. Neural and vascular contributions to sensory impairments in a human alpha-synuclein transgenic mouse model of Parkinson’s disease
    Ruxanda Lungu, Francisca F. Fernandes, Sara Pires Monteiro, Tiago F. Outeiro, Noam Shemesh · 2025 · Journal of Cerebral Blood Flow & Metabolism
62. Capsaicin and nicotine alleviate MPTP induced olfactory dysfunction by suppressing cGAS/TBK1/STING and MAPK mediated neuroinflammation
    Jingjing Wei, Linhai Wang, Dingzhong Wang, Weiwei Chen, Lulu Guo, Mengqian Ren, Fangxin Guo, Sisi Ruan, Hangcui Hu, Yao Zheng et al. · 2025 · npj Parkinson s Disease
63. Mapping cellular vulnerability in Parkinson’s disease using retro-AAVs and preformed α-synuclein fibrils
    Fanni F. Geibl, Ahmed A. S. Musa, Leo Dietrich, Helena Kern Wolter, David L. Wokosin, Sharof Khudayberdiev, Marco B. Rust, Rong Chen, Valina Lynn Dawson, Ted M. Dawson et al. · 2026 · Translational Neurodegeneration
64. Neuronal vulnerability in Parkinson’s disease: insights from murine α-synuclein pathology models
    Ziba Asadpoordezaki, Jochen H.M. Prehn · 2026 · Neuroscience
65. Development of convolutional neural networks for automated brain-wide histopathological analysis in mouse models of synucleinopathies
    Anna Barber Janer, Eva Van Acker, Eline Vonck, Dieter Plessers, Francesco Rosada, Chris Van den Haute, Veerle Baekelandt, Wouter Peelaerts · 2025 · npj Parkinson s Disease
66. Increased oscillatory power in a computational model of the olfactory bulb due to synaptic degeneration
    J. Kendall Berry, Daniel Lee Cox · 2021 · Physical review. E
67. Perturbation of in vivo neural activity following α-Synuclein seeding in the olfactory bulb
    Aishwarya S. Kulkarni, María del Mar Cortijo, Elizabeth R. Roberts, Tamara L. Suggs, Heather B. Stover, Jose Ignacio Pena-Bravo, Jennifer A. Steiner, Kelvin C. Luk, Patrik Brundin, Daniel W. Wesson · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
68. Quantitative Study of Alpha-Synuclein Prion-Like Spreading in Fully Oriented Reconstructed Neural Networks Reveals Non-synaptic Dissemination of Seeding Aggregates
    Josquin Courte, Ngoc Anh Le, Luc Bousset, Ronald Melki, Catherine Villard, Jean‐Michel Peyrin · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
69. Inhibiting MARS attenuates hyperhomocysteinemia-associated neurodegeneration in Parkinson's disease
    Tao Guo, Dandan Su, Juan Huang, Guohua Zhao, Xin Fang, Ting Yu, Shangqi Sun, Anyu Bao, Lihong Bu, Zhentao Zhang · 2025 · Neuropharmacology
70. Spreading of alpha-synuclein pathology from the gut to the brain in Parkinson's disease
    Benjamin Jevans, Donato A. Di Monte · 2021 · International review of movement disorders
71. Mitochondrial dysfunction underlies cortical atrophy in prodromal synucleinopathies
    Shady Rahayel, Christina Tremblay, Andrew Vo, Bratislav Mišić, Stéphane Lehéricy, Isabelle Arnulf, Marie Vidailhet, Jean‐Christophe Corvol, the ICEBERG Study Group, Jean‐François Gagnon et al. · 2022 · medRxiv
72. Silent Spread: Olfactory Bulb α-Synuclein Seeding in Wild-Type Mice Drives Pathology and Transient Neuroinflammation While Sparing Function
    Annelore Anthonissen, Diana Iordache, Noé Vincent, Wim Van der Elst, Wilhelmus H. I. M. Drinkenburg, Patrik Verstreken, Juan D. Pita‐Almenar, Hervé Maurin, Abdallah Ahnaou · 2026 · Research Square
73. An integrated genomic approach to dissect the genetic landscape regulating the cell-to-cell transfer of a-synuclein
    Eleanna Kara, Alessandro Crimi, Anne E. Wiedmer, Marc Emmenegger, Claudia Manzoni, Sara Bandrés‐Ciga, Karishma D’Sa, Regina Hertfelder Reynolds, Juan Antonio Botía, Marco Losa et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
74. Alpha-synuclein detection in olfactory mouse bulbs in ontogenesis in vivo and in the organotypic culture
    Д. Н. Воронков, А. А. Лыжин, Капкаева Марина Рафаилевна, Р. М. Худоерков, Л. Г. Хаспеков · 2019 · CLINICAL AND EXPERIMENTAL MORPHOLOGY
75. Alpha-synuclein spreading mechanisms in Parkinson's disease: The role of membrane receptors
    Inês Caldeira Brás, Tiago F. Outeiro · 2021 · International review of movement disorders
76. Phased-Resolved Strain Measuremetns in Hydrated Ordinary Portland Cement Using Synchrotron x-Rays (Prop. 2003-033)
    Joseph J. Biernacki, Thomas R. Watkins, C. J. Parnham, Camden Richards Hubbard, Jianming Bai · 2006 · Journal of the American Ceramic Society
77. An Integrated Genomic Approach to Dissect the Genetic Landscape Regulating the Cell-to-Cell Transfer of α-Synuclein
    Eleanna Kara, Alessandro Crimi, Anne E. Wiedmer, Marc Emmenegger, Claudia Manzoni, Sara Bandrés‐Ciga, Karishma D’Sa, Regina Hertfelder Reynolds, Juan Antonio Botía, Marco Losa et al. · 2022 · SSRN Electronic Journal
78. A topographical atlas of α-synuclein cell type-specific expression in adult mouse brain and peripheral organs
    Maxime W.C. Rousseaux, Haley M. Geertsma, Zoe A. Fisk, Lillian Sauline, Alice Prigent, Kevin Kurgat, Steve M. Callaghan, Julianna J. Tomlinson, Michael X. Henderson · 2023 · Research Square
79. Technique for Intranasal Administration of α-Synuclein Aggregates
    Masanori Sawamura, Ryōsuke Takahashi · 2024 · Journal of Visualized Experiments
80. Parkinson disease and Parkinsonism
    Michael Thomas Hayes · 2024 · Elsevier eBooks
81. Deep brain stimulation using animal models of Parkinson's disease
    Amena S. El-Feky, Fatma M. Ali, Fatima Mohamed Abbas, Hend H. Mohamed · 2024 · Elsevier eBooks
82. Amyloid, Tau, and ApoE: Revisiting Hypotheses of Alzheimer's Disease
    Bowen Yao, Minglu Kuang, Derrick Feng Jiang, Chihao Xu · 2025 · Theoretical and Natural Science
83. The potential of brain organoids in addressing the heterogeneity of synucleinopathies
    Xiao-Jun Diao, Claudio A. Soto, Fei Wang, Yu Wang, Yun‐Cheng Wu, Abhisek Mukherjee · 2025 · Cellular and Molecular Life Sciences
84. Spreading alpha-synuclein Oligomers Trigger Astrocyte Changes and Astrocyte-Glutamatergic Neuron system dysfunction in an Age-related Manner
    Jaehyun LeeBae, Verena Bopp, Alicia Goreth, Veselin Grozdanov, Julia K. Kühlwein, Ermanno Gazzola, Daniel Rombach, Laura Meier, Leda Dimou, Karin M. Danzer · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
85. Rodent models for exploring the mechanisms contributing to Parkinson's disease pathophysiology
    Joseph Allison, Susan Duty · 2025 · Handbook of behavioral neuroscience
86. Additional file 1 of Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
    Schaser, Allison J., Teresa L. Stackhouse, Leah J. Weston, Patrick C. Kerstein, Valerie R. Osterberg, López, Claudia S., Dennis W. Dickson, Kelvin C. Luk, Charles K. Meshul, Woltjer, Randall L. et al. · 2020 · Figshare
87. Additional file 13 of Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease
    Juan F. Reyes, Sara Ekmark‐Lewén, Μarina Perdiki, Therése Klingstedt, Hoffmann, Alana, Emilia Wiecheć, Nilsson, Per, K. Peter R. Nilsson, Alafuzoff, Irina, Ingelsson, Martin et al. · 2021 · Figshare
88. Additional file 10 of Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
    Schaser, Allison J., Teresa L. Stackhouse, Leah J. Weston, Patrick C. Kerstein, Valerie R. Osterberg, López, Claudia S., Dennis W. Dickson, Kelvin C. Luk, Charles K. Meshul, Woltjer, Randall L. et al. · 2020 · Figshare
89. Additional file 1 of Differential seeding and propagating efficiency of α-synuclein strains generated in different conditions
    Di Liu, Guo, Jian-Jun, Su, Ji-Hui, Alexander Svanbergsson, Yuan, Lin, Caroline Haikal, Li, Wen, Gunnar K. Gouras, Jiayi Li · 2021 · Figshare
90. Additional file 10 of Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease
    Juan F. Reyes, Sara Ekmark‐Lewén, Μarina Perdiki, Therése Klingstedt, Alana Hoffmann, Emilia Wiecheć, Nilsson, Per, K. Peter R. Nilsson, Alafuzoff, Irina, Ingelsson, Martin et al. · 2021 · Figshare
91. Additional file 2 of Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
    Schaser, Allison J., Teresa L. Stackhouse, Leah J. Weston, Patrick C. Kerstein, Valerie R. Osterberg, López, Claudia S., Dennis W. Dickson, Luk, Kelvin C., Charles K. Meshul, Woltjer, Randall L. et al. · 2020 · Figshare
92. Additional file 6 of Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
    Schaser, Allison J., Teresa L. Stackhouse, Leah J. Weston, Patrick C. Kerstein, Valerie R. Osterberg, López, Claudia S., Dennis W. Dickson, Luk, Kelvin C., Charles K. Meshul, Woltjer, Randall L. et al. · 2020 · Figshare
93. Additional file 12 of Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease
    Juan F. Reyes, Sara Ekmark‐Lewén, Μarina Perdiki, Therése Klingstedt, Alana Hoffmann, Emilia Wiecheć, Nilsson, Per, K. Peter R. Nilsson, Irina I. Alafuzoff, Ingelsson, Martin et al. · 2021 · Figshare
94. Additional file 7 of Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
    Schaser, Allison J., Teresa L. Stackhouse, Leah J. Weston, Patrick C. Kerstein, Valerie R. Osterberg, López, Claudia S., Dennis W. Dickson, Luk, Kelvin C., Charles K. Meshul, Woltjer, Randall L. et al. · 2020 · Figshare
95. Additional file 11 of Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease
    Juan F. Reyes, Sara Ekmark‐Lewén, Μarina Perdiki, Therése Klingstedt, Alana Hoffmann, Emilia Wiecheć, Nilsson, Per, K. Peter R. Nilsson, Alafuzoff, Irina, Ingelsson, Martin et al. · 2021 · Figshare
96. Additional file 5 of Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
    Schaser, Allison J., Teresa L. Stackhouse, Leah J. Weston, Patrick C. Kerstein, Valerie R. Osterberg, López, Claudia S., Dennis W. Dickson, Kelvin C. Luk, Charles K. Meshul, Woltjer, Randall L. et al. · 2020 · Figshare
97. Additional file 11 of Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
    Schaser, Allison J., Teresa L. Stackhouse, Leah J. Weston, Patrick C. Kerstein, Valerie R. Osterberg, López, Claudia S., Dennis W. Dickson, Kelvin C. Luk, Charles K. Meshul, Woltjer, Randall L. et al. · 2020 · Figshare
98. Additional file 3 of Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
    Schaser, Allison J., Teresa L. Stackhouse, Leah J. Weston, Patrick C. Kerstein, Valerie R. Osterberg, López, Claudia S., Dennis W. Dickson, Luk, Kelvin C., Charles K. Meshul, Woltjer, Randall L. et al. · 2020 · Figshare
99. Additional file 4 of Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
    Schaser, Allison J., Teresa L. Stackhouse, Leah J. Weston, Patrick C. Kerstein, Valerie R. Osterberg, López, Claudia S., Dennis W. Dickson, Kelvin C. Luk, Charles K. Meshul, Woltjer, Randall L. et al. · 2020 · Figshare
100. Additional file 12 of Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
     Schaser, Allison J., Teresa L. Stackhouse, Leah J. Weston, Patrick C. Kerstein, Valerie R. Osterberg, López, Claudia S., Dennis W. Dickson, Kelvin C. Luk, Charles K. Meshul, Woltjer, Randall L. et al. · 2020 · Figshare